Skip to main content
×
×
Home

Antipsychotic-induced akathisia in delirium: A systematic review

  • Fernando Espi Forcen (a1), Konstantina Matsoukas (a1) and Yesne Alici (a1)
Abstract
Objective:

Akathisia is a neuropsychiatric syndrome characterized by subjective and objective restlessness. It is a common side effect in patients taking antipsychotics and other psychotropics. Patients with delirium are frequently treated with antipsychotic medications that are well known to induce akathisia as a side effect. However, the prevalence, phenomenology, and management of akathisia in patients with delirium remain largely unknown. The purpose of this review was to examine the medical literature in order to establish the current state of knowledge regarding the prevalence of antipsychotic-induced akathisia in patients with delirium.

Method:

A systematic review of the literature was conducted using the EMBASE, MEDLINE, PsycINFO, and CINAHL databases. Ten studies addressing the incidence of akathisia in patients taking antipsychotic medication for delirium were identified and included in our review.

Results:

The included studies reported a variable prevalence of antipsychotic-induced akathisia. A higher prevalence was found in patients taking haloperidol. Among atypical antipsychotics, paliperidone and ziprasidone were associated with a higher risk of akathisia. The risk for akathisia appeared to be a dose-related phenomenon.

Significance of results:

Studies using specific scales for evaluation of akathisia in delirium are lacking. Some populations, such as patients with cancer or terminally ill patients in palliative care settings taking antipsychotics for the treatment of delirium, could be at higher risk for development of akathisia as a side effect.

Copyright
Corresponding author
Address correspondence and reprint requests to: Fernando Espi Forcen, 425 East 76th Street, Apartment 4B, New York, New York 10021. E-mail: ferespi@hotmail.com
References
Hide All
American Psychiatric Association (APA) (2013). Diagnostic and statistical manual of mental disorders, 5th ed. [DSM–V]. Arlington, VA: American Psychiatric Publishing.
Barnes, T. & Braude, W. (1985). Akathisia variants and tardive dyskinesia. Archives of General Psychiatry, 42(9), 874878.
Berrios, G.E. (1995). Lad Haskovec and akathisia. History of Psychiatry, 6(22, Pt. 2), 243251.
Breitbart, W. & Alici, Y. (2012). Evidence-based treatment of delirium in patients with cancer. Journal of Clinical Oncology, 30(11), 12061214.
Breitbart, W., Marotta, R., Platt, M.M., et al. (1996). A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. The American Journal of Psychiatry, 153(2), 231237.
Crawford, G.B., Meera Agar, M., Quinn, S.J., et al. (2013). Pharmaco-vigilance in hospice/palliative care: Net effect of haloperidol for delirium. Journal of Palliative Medicine, 16(11), 13351341.
Fernandez, F. & Levy, J.K. (1993). The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus: Case reports. General Hospital Psychiatry, 15(1), 3135.
Fleischhacker, W.W., Miller, C.H., Schett, P., et al. (1991). The Hillside Akathisia Scale: A reliability comparison of the English and German versions. Psychopharmacology, 105(1), 141144.
Frazier, J.A., McClellan, J, Findling, R.L., et al. (2007). Treatment of early-onset schizophrenia spectrum disorders (TEOSS): Demographic and clinical characteristics. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 979988.
Friedman, J.I., Soleimani, L., McGonigle, D.P., et al. (2014). Pharmacological treatments of non-substance-withdrawal delirium: A systematic review of prospective trials. The American Journal of Psychiatry, 171(2), 151159.
Gogtay, N. & Rapoport, J. (2008). Clozapine use in children and adolescents. Expert Opinion on Pharmacotherapy, 9(3), 459465.
Gilchrist, N.A., Asoh, I. & Greenberg, B. (2012). Atypical antipsychotics for the treatment of ICU delirium. Journal of Intensive Care Medicine, 27(6), 354361.
Girard, T.D., Pandharipande, P.P., Carson, S.S., et al. (2010). Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Critical Care Medicine, 38(2), 428437.
Han, C.S. & Kim, Y.K. (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics, 45(4), 297301.
Hatta, K., Kishi, Y., Wada, K., et al. (2014). Antipsychotics for delirium in the general hospital setting in 2453 consecutive inpatients: A prospective observational study. International Journal of Geriatric Psychiatry, 29(3), 253262.
Jung Jin, K., Hyun Kook, L., Chi Un, P., et al. (2009). Comparison of intramuscular olanzapine and haloperidol for the treatment of delirium. European Psychiatry, 24, S1006.
Jung, J.S., Lee, H.J., Cho, C.H., et al. (2014). Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphism in schizophrenia. Chronobiology International, 31(7), 838844.
Kalisvaart, K.J., de Jonghe, J.F., Bogaards, M.J., et al. (2005). Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. Journal of the American Geriatrics Society, 53(10), 16581666.
Kawanishi, C., Onishi, H., Kato, D., et al. (2007). Unexpectedly high prevalence of akathisia in cancer patients. Palliative & Supportive Care, 5(4), 351354.
Kim, J.H., Kim, Y.B., Lee, S.Y., et al. (2011). Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: A high-resolution PET study with [11C]raclopride. Journal of Clinical Psychopharmacology, 31(4), 507511.
Kim, J.J., Lim, H.K., Pae, C.U., et al. (2008). Comparison of intramuscular olanzapine and haloperidol for the treatment of delirium. European Neuropsychopharmacology, 18(S4), S424S425.
Kim, S.W., Yoo, J.A., Lee, S.Y., et al. (2010). Risperidone versus olanzapine for the treatment of delirium. Human Psychopharmacology, 25(4), 298302.
Kumar, R. & Sachdev, P. (2009). Akathisia and second-generation antipsychotic drugs. Current Opinion in Psychiatry, 22(3), 293299.
Lieberman, J.A. & Stroup, T.S. (2011). The NIMH–CATIE schizophrenia study: What did we learn? The American Journal of Psychiatry, 168(8), 770775.
Lonergan, E., Britton, A.M. & Luxenberg, J. (2007). Antipsychotics for delirium. The Cochrane Database of Systematic Reviews, (2), CD005594.
Loonen, A.J.M. & Stahl, S.M. (2011). The mechanism of drug-induced akathisia. CNS Spectrums, 16(1), 710.
Maneeton, B., Maneeton, N., Srisurapanont, M., et al. (2013). Quetiapine versus haloperidol in the treatment of delirium: A double-blind, randomized, controlled trial. Drug Design, Development and Therapy, 7, 657667.
Menza, M.A., Murray, G.B., Holmes, V.F., et al. (1988). Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: Intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart & Lung, 17(3), 238241.
Miyaji, S., Yamamoto, K., Hoshino, S., et al. (2007). Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry and Clinical Neurosciences, 61(3), 275282.
Ossowska, K. (2002). Neuronal basis of neuroleptic-induced extrapyramidal side effects. Polish Journal of Pharmacology, 54(4), 299312.
Page, V.J., Ely, E.W., Gates, S., et al. (2013). Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope–ICU): A randomised, double-blind, placebo-controlled trial. The Lancet, Respiratory Medicine, 1(7), 515523.
Pintor, L., Fuente, E., Bailles, E., et al. (2009). Study on the efficacy and tolerability of amisulpride in medical/surgical inpatients with delirium admitted to a general hospital. European Psychiatry, 24(7), 450455.
Sachdev, P. (1994). A rating scale for acute drug-induced akathisia: Development, reliability, and validity. Biological Psychiatry, 35(4), 263–71.
Sachdev, P. (1995). Akathisia and restless legs. Cambridge: Cambridge University Press.
Sachdev, P. & Loneragan, C. (1991) The present status of akathisia. The Journal of Nervous and Mental Disease, 179(7), 381391.
Seneff, M.G. & Mathews, R.A. (1995). Use of haloperidol infusions to control delirium in critically ill adults. The Annals of Pharmacotherapy, 29(7–8), 690693.
Takeuchi, T., Furuta, K., Hirasawa, T., et al. (2007). Perospirone in the treatment of patients with delirium. Psychiatry and Clinical Neurosciences, 61(1), 6770.
Wada, M., Ito, H., Wada, M., et al. (2011). Drug-induced akathisia as a cause of distress in spouse caregivers of cancer patients. Palliative & Supportive Care, 9(2), 209212.
White, C., McCann, M.A. & Jackson, N. (2007). First do no harm … Terminal restlessness or drug-induced delirium. Journal of Palliative Medicine, 10(2), 345351.
Yoo, J.A., Kim, S.W., Bae, K.Y., et al. (2011). Risperidone versus olanzapine for the treatment of delirium. European Neuropsychopharmacology, 21, S493.
Yoon, H.K., Kim, Y.K., Han, C., et al. (2011). Paliperidone in the treatment of delirium: Results of a prospective open-label pilot trial. Acta Neuropsychiatrica, 23(4), 179.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Palliative & Supportive Care
  • ISSN: 1478-9515
  • EISSN: 1478-9523
  • URL: /core/journals/palliative-and-supportive-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed